
Loblaw Companies Limited delivered robust Q2 2025 performance, with revenue up 5.2% to CAD 14.5 billion and adjusted diluted EPS increasing 11.6% to CAD 2.40, fueled by strategic store expansions, digital innovation, and operational efficiencies. The company is on track to open 80 new stores this year, including successful U.S. expansion of its T&T brand, and is leveraging AI for supply chain and in-store improvements. Despite a challenging retail landscape, Loblaw reaffirmed its full-year outlook, projecting continued top-line growth and stable margins, and announced a 4-for-1 stock split effective August 2025.
Loblaw Companies Limited reported a robust Q2 2025, with revenue increasing 5.2% to CAD 14.5 billion and adjusted diluted EPS growing 11.6% to CAD 2.40, exceeding expectations. This strong performance was driven by strategic store expansions, particularly in discount formats and the successful U.S. T&T brand, alongside significant operational efficiencies. Adjusted EBITDA also rose 7.4% to CAD 1.8 billion, demonstrating broad-based strength. The company's focus on digital innovation and AI integration is yielding tangible benefits, with online sales up 17.5% and AI-driven tools like "Robin" enhancing in-store and supply chain efficiencies. Loblaw's new East Gwillimbury distribution center is ahead of schedule, with capacity utilization projected to increase from 40% to 60% by year-end, contributing to cost savings. The 4-for-1 stock split effective August 2025 signals management's confidence in future growth. Despite a challenging retail environment marked by consumer price sensitivity and slowing credit card spend, Loblaw's value proposition, particularly through its discount banners, has driven market share gains. Management remains confident in achieving its full-year outlook, projecting continued top-line growth and stable gross margins, although it has not yet revised guidance upward due to macro uncertainties. The successful expansion of pharmacy clinics and the strong performance of the beauty category at Shoppers Drug Mart further diversify revenue streams.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment